In a significant move within the healthtech industry, UK-based platform MANUAL has acquired Germany’s FORMEL SKIN—a leading digital dermatology provider. Both companies are poised to form an influential healthtech group in Europe, driven by a shared aim of creating a global health platform. The acquisition signals MANUAL’s expansion into specialized digital healthcare and represents FORMEL SKIN’s ambition to broaden its healthcare offerings. The focus is on integrating technology and healthcare services to enhance accessibility for patients, increasing the scope of services beyond dermatology.
What Stands Behind FORMEL SKIN’s Growth?
FORMEL SKIN has made impressive strides since its establishment in 2019, offering over two million personalized dermatological treatments via a digital platform. The company has consistently narrowed the gap between expert medical guidance and everyday skin health management. Its successful partnerships with renowned European universities and innovative treatment protocols have resulted in a 90% improvement in treatment outcomes. FORMEL SKIN’s approach has not only set a benchmark for digital dermatological care in Europe but has also built a robust user base with tens of thousands of monthly users.
What Lies Ahead for MANUAL and FORMEL SKIN?
The acquisition marks a pivotal moment for both companies. By aligning with MANUAL, FORMEL SKIN aims to accelerate its mission, extending its reach beyond dermatology. This strategic partnership aims to provide improved patient outcomes for diverse health conditions, tapping into new markets across Europe. Founder and CEO Florian Semler emphasized this evolution by stating,
“For six years, we’ve been on a mission to make dermatology more accessible and to build a platform that serves millions of patients. From humble beginnings, FORMEL SKIN has grown into Europe’s leading digital dermatology provider.”
Furthermore, MANUAL’s perspective highlights their admiration for FORMEL SKIN’s success and the synergy seen with future plans. George Pallis, Founder and CEO of MANUAL, recognized FORMEL SKIN’s accomplishments saying,
“We’re deeply impressed by FORMEL SKIN’s achievements since its founding in 2019 and enthusiastic about the company’s future growth potential.”
As the collaboration advances, the newly branded entity, VOY, plans to launch an advanced medically supervised weight loss program in Germany. This initiative combines personalized and clinically proven treatments with comprehensive lifestyle and behavioral support, broadening the healthcare services on offer.
In previous developments, FORMEL SKIN had already set itself apart in the digital dermatology space by prioritizing patient empowerment and accessibility. The alliance with MANUAL further amplifies this ethos, aiming to reach a larger demographic and improve digital health outcomes.
Through this acquisition, both MANUAL and FORMEL SKIN plan to set new standards in digital healthcare delivery. The anticipated synergy is expected to leverage technology for wider, more efficient healthcare access and offer comprehensive, patient-centered care. As the healthtech landscape evolves, such alliances could pioneer a more cohesive digital health framework, addressing varied healthcare needs in a single, unified platform. This collaboration underlines an industry shift toward integrating specialized digital health services into broader healthcare solutions.
